CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
paper
Cited
Public
Unavailable
- Authors
- Chen, Li-Shiun; Hung, Rayjean J; Baker, Timothy; Horton, Amy; Culverhouse, Rob; Saccone, Nancy; Cheng, Iona; Deng, Bo; Han, Younghun; Hansen, Helen M; Horsman, Janet; Kim, Claire; Lutz, Sharon; Rosenberger, Albert; Aben, Katja K; Andrew, Angeline S; Breslau, Naomi; Chang, Shen-Chih; Dieffenbach, Aida Karina; Dienemann, Hendrik; Frederiksen, Brittni; Han, Jiali; Hatsukami, Dorothy K; Johnson, Eric O; Pande, Mala; Wrensch, Margaret R; McLaughlin, John; Skaug, Vidar; van der Heijden, Henricus F; Wampfler, Jason; Wenzlaff, Angela; Woll, Penella; Zienolddiny, Shanbeh; Bickeböller, Heike; Brenner, Hermann; Duell, Eric J; Haugen, Aage; Heinrich, Joachim; Hokanson, John E; Hunter, David J; Kiemeney, Lambertus A; Lazarus, Philip; Le Marchand, Loic; Liu, Geoffrey; Mayordomo, Jose; Risch, Angela; Schwartz, Ann G; Teare, Dawn; Wu, Xifeng; Wiencke, John K; Yang, Ping; Zhang, Zuo-Feng; Spitz, Margaret R; Kraft, Peter; Amos, Christopher I; Bierut, Laura J
- Year
- 2015
- Journal
- Journal of the National Cancer Institute
- PMID
- 25873736
- DOI
- 10.1093/jnci/djv100
- PMCID
- PMC4822525
BACKGROUND: Recent meta-analyses show strong evidence of associations among genetic variants in CHRNA5 on chromosome 15q25, smoking quantity, and lung cancer. This meta-analysis tests whether the CHRNA5 variant rs16969968 predicts age of smoking cessation and age of lung cancer diagnosis. METHODS: Meta-analyses examined associations between rs16969968, age of quitting smoking, and age of lung cancer diagnosis in 24 studies of European ancestry (n = 29 072). In each dataset, we used Cox regression models to evaluate the association between rs16969968 and the two primary phenotypes (age of smoking cessation among ever smokers and age of lung cancer diagnosis among lung cancer case patients) and the secondary phenotype of smoking duration. Heterogeneity across studies was assessed with the Cochran Q test. All statistical tests were two-sided. RESULTS: The rs16969968 allele (A) was associated with a lower likelihood of smoking cessation (hazard ratio [HR] = 0.95, 95% confidence interval [CI] = 0.91 to 0.98, P = .0042), and the AA genotype was associated with a four-year delay in median age of quitting compared with the GG genotype. Among smokers with lung cancer diagnoses, the rs16969968 genotype (AA) was associated with a four-year earlier median age of diagnosis compared with the low-risk genotype (GG) (HR = 1.08, 95% CI = 1.04 to 1.12, P = 1.1*10(-5)). CONCLUSION: These data support the clinical significance of the CHRNA5 variant rs16969968. It predicts delayed smoking cessation and an earlier age of lung cancer diagnosis in this meta-analysis. Given the existing evidence that this CHRNA5 variant predicts favorable response to cessation pharmacotherapy, these findings underscore the potential clinical and public health importance of rs16969968 in CHRNA5 in relation to smoking cessation success and lung cancer risk.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. | Carbone M et al. | — | 2026 | → |
| Single nucleotide variants in lung cancer. | Tian X et al. | — | 2024 | → |
| Smoking-Related Increases in Alcohol Outcomes and Preliminary Evidence for the Protective Effect of a Functional Nicotine Receptor Gene (CHRNA5) Variant on Alcohol Consumption in Individuals Without Alcohol Use Disorder. | Venkatesh SK et al. | — | 2024 | → |
| Challenges in studying the interplay of genes and environment. A study of childhood financial distress moderating genetic predisposition for peak smoking. | Bierut L et al. | — | 2023 | → |
| CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women. | Jones SK et al. | — | 2023 | → |
| Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment. | Chen LS et al. | — | 2023 | → |
| Are polygenic risk scores ready for the cancer clinic?-a perspective. | Klein RJ et al. | — | 2022 | → |
| A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation. | Jones SK et al. | — | 2022 | → |
| Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits. | Muderrisoglu A et al. | — | 2022 | → |
| The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials. | Bray M et al. | — | 2022 | → |
| Association of the Uncoupling Protein 2-866 G/A Polymorphism with Family History and Duration of Tobacco Use Disorder in a Turkish Population. | Mervan Aytac H et al. | — | 2021 | → |
| Effects of tobacco and vaping on the skin. | Mitri A et al. | — | 2021 | → |
| Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms. | Brynildsen JK et al. | — | 2021 | → |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | — | 2021 | → |
| Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette Smoking. | Ramsey AT et al. | — | 2021 | → |
| Rare deleterious germline variants and risk of lung cancer. | Liu Y et al. | — | 2021 | → |
| 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation. | Bierut LJ | — | 2020 | → |
| Association of TERT, OGG1, and CHRNA5 Polymorphisms and the Predisposition to Lung Cancer in Eastern Algeria. | Mimouni A et al. | — | 2020 | → |
| Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study. | Sondermeijer L et al. | — | 2020 | → |
| Do Nicotinic Receptors Modulate High-Order Cognitive Processing? | Koukouli F et al. | — | 2020 | → |
| Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution. | Icick R et al. | — | 2020 | → |
| Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial. | Chen LS et al. | — | 2020 | → |
| Identification of <i>slit3</i> as a locus affecting nicotine preference in zebrafish and human smoking behaviour. | García-González J et al. | — | 2020 | → |
| Participatory Design of a Personalized Genetic Risk Tool to Promote Behavioral Health. | Ramsey AT et al. | — | 2020 | → |
| Translational Molecular Approaches in Substance Abuse Research. | Fulton SL et al. | — | 2020 | → |
| Acetylcholine signaling system in progression of lung cancers. | Friedman JR et al. | — | 2019 | → |
| Association Between rs1051730 and Smoking During Pregnancy in Dutch Women. | Mbarek H et al. | — | 2019 | → |
| Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop. | Chang CM et al. | — | 2019 | → |
| Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. | Lutz SM et al. | — | 2019 | → |
| Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma. | Lin CH et al. | — | 2019 | → |
| Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer. | Zhao S et al. | — | 2019 | → |
| Using genomic profiling for understanding and improving response to smoking cessation treatment. | Bierut LJ | — | 2019 | → |
| A hierarchical clustering method for dimension reduction in joint analysis of multiple phenotypes. | Liang X et al. | — | 2018 | → |
| A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats. | Forget B et al. | — | 2018 | → |
| Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. | Tomaz PRX et al. | — | 2018 | → |
| CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population. | Ayesh BM et al. | — | 2018 | → |
| Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. | Rosenberger A et al. | — | 2018 | → |
| Genome-Wide Association Study of Heavy Smoking and Daily/Nondaily Smoking in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). | Saccone NL et al. | — | 2018 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5' and 3'-Regions. | Aziz HA et al. | — | 2018 | → |
| Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum. | Wolfman SL et al. | — | 2018 | → |
| Pathways to precision medicine in smoking cessation treatments. | Chen LS et al. | — | 2018 | → |
| Preparing the Way: Exploiting Genomic Medicine to Stop Smoking. | Bierut LJ et al. | — | 2018 | → |
| The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. | Saccone NL et al. | — | 2018 | → |
| Toward the implementation of genomic applications for smoking cessation and smoking-related diseases. | Ramsey AT et al. | — | 2018 | → |
| Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors. | Chen LS et al. | — | 2018 | → |
| A general approach to testing for pleiotropy with rare and common variants. | Lutz SM et al. | — | 2017 | → |
| Alpha5 Nicotinic Acetylcholine Receptor Contributes to Nicotine-Induced Lung Cancer Development and Progression. | Sun HJ et al. | — | 2017 | → |
| Evaluation of a Novel Difficulty of Smoking Cessation Phenotype Based on Number of Quit Attempts. | Stevens VL et al. | — | 2017 | → |
| Genetics of addictive behavior: the example of nicotine dependence. | Gorwood P et al. | — | 2017 | → |
| Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies. | Patel CJ et al. | — | 2017 | → |
| Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers. | Hecht SS | — | 2017 | → |
| Pharmacogenetic Optimization of Smoking Cessation Treatment. | Chenoweth MJ et al. | — | 2017 | → |
| Phenome-wide association study for CYP2A6 alleles: rs113288603 is associated with hearing loss symptoms in elderly smokers. | Polimanti R et al. | — | 2017 | → |
| Screening and Early Detection of Lung Cancer. | Eggert JA et al. | — | 2017 | → |
| The 2016 Ferno Award Address: Three Things. | Baker TB | — | 2017 | → |
| Associations between smoking behavior-related alleles and the risk of melanoma. | Wu W et al. | — | 2016 | → |
| Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. | Chen LS et al. | — | 2016 | → |
| Genetics of Substance Use Disorders. | Yu C et al. | — | 2016 | → |
| Phenome-Wide Association Study for Alcohol and Nicotine Risk Alleles in 26394 Women. | Polimanti R et al. | — | 2016 | → |
| Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. | Chen LS et al. | — | 2015 | → |
| The value of control conditions for evaluating pharmacogenetic effects. | Chen LS et al. | — | 2015 | → |